Investigating the role of aspirin on the mortality risk of sepsis-associated encephalopathy: a retrospective study
Aspirin could reduce the mortality risk of SAE patients for in-hospital, 30-day, 60-day, 90-day, and 180-day, without increasing the risk of gastrointestinal hemorrhage. The benefits observed persisted regardless of aspirin exposure timing. Patients received high-dose aspirin exhibited a higher mortality risk compared to those in the low-dose group.
Authors
- Xiaoxiang Gong (ORCID: https://orcid.org/0000-0003-2322-1298)
- Qiuli Li (ORCID: https://orcid.org/0000-0002-7280-5508)
- Heng Meng (ORCID: https://orcid.org/0000-0002-8859-6042)
- Dongyou Yue (ORCID: https://orcid.org/0000-0002-9617-8203)
- Fengzhen Huang (ORCID: https://orcid.org/0000-0003-4512-5600)
- Tieqiao Zhou
- Jiping Yi (ORCID: https://orcid.org/0009-0008-0465-039X)
Institutions
- Central South University (CN)
- Chenzhou First People's Hospital (CN)
- Second Xiangya Hospital of Central South University (CN)
- First Affiliated Hospital of Jinan University (CN)
- Xiangnan University (CN)
- University of South China (CN)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-03-26
- DOI
- https://doi.org/10.3389/fneur.2025.1521043
- Citations
- 1
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35